Thane, India

Jatin Jagdish Gajjar


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jatin Jagdish Gajjar: Innovator in Pharmaceutical Technology

Introduction

Jatin Jagdish Gajjar is a notable inventor based in Thane, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy and safety of pharmaceutical compositions.

Latest Patents

Jatin holds a patent for a pre-filled syringe containing sugammadex. This invention outlines a method for providing a sterile pharmaceutical composition in a pre-filled syringe. The method includes solubilizing an active agent and a pH adjusting agent in a solvent to create a pharmaceutical composition. It also involves filtering the composition through a membrane to ensure sterility. The pre-filled syringe is designed with a headspace volume of less than 7.5% of the labeled size, and the method avoids any heat-based sterilization processes. This innovative approach contributes to the field by providing sterile pharmaceutical compositions that are both effective and safe for use.

Career Highlights

Jatin is currently employed at Par Pharmaceutical, Inc., where he continues to work on advancing pharmaceutical technologies. His expertise in drug formulation and delivery systems has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Jatin has collaborated with several professionals, including Atul Arvind Bodkhe and Satish Shamlal Patil. These collaborations have fostered a productive environment for innovation and development in pharmaceutical research.

Conclusion

Jatin Jagdish Gajjar is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions to drug delivery systems. His patent for a pre-filled syringe containing sugammadex exemplifies his commitment to improving pharmaceutical technologies. His work continues to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…